Endologix (ELGX)
Endologix Market Cap: 830.23M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
ELGX Market Cap Rankings
| Overall | 58th percentile | 1938 of 4649 |
| Sector | 70th percentile | 154 of 525 in Healthcare |
| Industry | 67th percentile | 22 of 68 in Medical Instruments & Supplies |
ELGX Market Cap Range, Past 5 Years
| Minimum | 52.38M | Dec 2008 |
| Maximum | 852.34M | Mar 2012 |
| Average | 307.90M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these ELGX related companies
ELGX News
Endologix's CEO Presents at the 2012 Bank of America Merrill Lynch Health Care Conference (Transcript)
May 16, 9:42PM Seeking Alpha
May 16, 9:42PM Seeking Alpha
Endologix to Present at the 2012 Bank of America Merrill Lynch Health Care Conference
May 09, 8:30AM GlobeNewswire
May 09, 8:30AM GlobeNewswire
EBR: Watchlist/worksheet/4 Trading Ideas: $DF $EQR $ENOC $AFFX $ELGX $OFC http://stks.co/3hIf
about 22 days ago by TheEquitiesRoom
about 22 days ago by TheEquitiesRoom
$ELGX Insider Sale: $2M of stock sold by Stefan Schreck on May 1, 2012 http://stks.co/3cAi
about 27 days ago by MarketBrief
about 27 days ago by MarketBrief
Listen to $ELGX Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3XWb
about 33 days ago by earningscast
about 33 days ago by earningscast
Endologix to Report First Quarter 2012 Financial Results on April 26, 2012
Apr 12, 9:00AM GlobeNewswire
Apr 12, 9:00AM GlobeNewswire
Oppenheimer Lifts Numbers on Endologix (ELGX) On Higher Nellix Expectations
Mar 14, 7:50AM Street Insider
Mar 14, 7:50AM Street Insider
The Street| 5 stocks poised for breakouts: $GS $ZAGG $SLXP $ONTY $ELGX http://stks.co/2bRx
about 90 days ago by abubnic
about 90 days ago by abubnic
Listen to $ELGX Q4 2011 earnings call - live at 05:00 PM, ondemand after - http://stks.co/2WD6
about 96 days ago by earningscast
about 96 days ago by earningscast
$ELGX Reports Q4 EPS $(0.06) vs $(0.05) Est; Revenues $23.39M vs $23.67M Est
about 97 days ago by Benzinga
about 97 days ago by Benzinga
Endologix Reports 24% and 22% Revenue Growth for the Full Year and Fourth Quarter 2011
Feb 22, 4:05PM GlobeNewswire
Feb 22, 4:05PM GlobeNewswire
$ELGX http://stks.co/2QEt from watch list over lower line and near second on volume of 29% full day average
about 104 days ago by StockTiger
about 104 days ago by StockTiger
Market Wrap Video + Additions to Watch List http://stks.co/2OR5 including: $ORLY $INCY $STEM $HLS $ELGX $CAM $CZZ
about 105 days ago by StockTiger
about 105 days ago by StockTiger
Market Wrap Video + Additions to Watch List http://stks.co/2NyU including: $ORLY $INCY $STEM $HLS $ELGX $CAM $CZZ
about 105 days ago by StockTiger
about 105 days ago by StockTiger
Endologix to Report Fourth Quarter and Full Year 2011 Financial Results on February 22, 2012
Feb 10, 9:00AM GlobeNewswire
Feb 10, 9:00AM GlobeNewswire
Endologix Announces First Patient Treated in Ventana(TM) U.S. Clinical Trial
Jan 31, 12:34PM Benzinga
Jan 31, 12:34PM Benzinga
Endologix Management Presents at JPMorgan Global Healthcare Conference (Transcript)
Jan 11, 2:50PM Seeking Alpha
Jan 11, 2:50PM Seeking Alpha
Endologix to Present at the 30th Annual J.P. Morgan Healthcare Conference
Jan 03, 4:30PM GlobeNewswire
Jan 03, 4:30PM GlobeNewswire
Endologix Management Presents at Oppenheimer 22nd Annual Healthcare Conference - Conference Call Transcript
Dec 13, 11:00PM Seeking Alpha
Dec 13, 11:00PM Seeking Alpha
Endologix's CEO Presents at Oppenheimer 22nd Annual Healthcare Conference - Event Transcript
Dec 13, 11:00PM Seeking Alpha
Dec 13, 11:00PM Seeking Alpha
Endologix's CEO Hosts Lazard Capital Markets 8th Annual Healthcare Conference Call Transcript
Nov 16, 2:04PM Seeking Alpha
Nov 16, 2:04PM Seeking Alpha
Endologix's CEO Presents at Stephens Inc. Fall Investment Conference - Conference Call Transcript
Nov 15, 4:55PM Seeking Alpha
Nov 15, 4:55PM Seeking Alpha
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ELGX | 14.27 | +0.19 | +1.35% | 830.23M |
| EL | 54.96 | -0.13 | -0.24% | 21.31B |
| EKH | 50.95 | +0.00 | +0.00% | |
| EJ | 5.59 | +0.14 | +2.57% | 461.01M |
| EIX | 45.00 | +0.15 | +0.33% | 14.66B |
| EIRL | 20.45 | +0.06 | +0.29% | |
| EIP | 14.78 | +0.01 | +0.07% | |
| EFII | 15.44 | -0.12 | -0.77% | 709.62M |
| EFG | 51.82 | -0.13 | -0.25% | |
| EFC | 21.41 | +0.11 | +0.52% | 353.05M |